Renmin Hospital, Hubei Medical University, Shiyan, China.
Mol Cells. 2011 Jul;32(1):39-45. doi: 10.1007/s10059-011-2315-5. Epub 2011 May 3.
The Octamer 4 gene (Oct4) is a master pluripotency controller that has been detected in several types of tumors. Here, we examine the expression of Oct4 in human esophageal squamous cell carcinoma (ESCC). We found that punctate Oct4 protein was expressed in most (93.7%) ESCC samples but it was not observed in esophageal mucosa. Some ESCC cells had the capacity to form tumorospheres; those with an Oct4(+)-rich cell phenotype had increased proliferation and Oct4 mRNA levels compared to those of differentiated cells in culture or xenograft tumors. The over-expression of Oct4 in ESCCs suggests that it is a potential target for ESCC therapy. Oct4 could be a useful tumor marker in an immunohistochemical panel designed to differentiate between ESCC and esophageal mucosa. Expression of Oct4 in tumorospheres might indicate the presence of a population of ECSCs and its expression in xenograft tumors suggests that Oct4 is also associated with tumor metastasis.
八聚体 4 基因(Oct4)是一种多能性主控因子,已在多种类型的肿瘤中被检测到。在这里,我们检查了人食管鳞状细胞癌(ESCC)中 Oct4 的表达。我们发现点状 Oct4 蛋白在大多数(93.7%)ESCC 样本中表达,但在食管黏膜中未观察到。一些 ESCC 细胞具有形成肿瘤球的能力;与培养或异种移植肿瘤中的分化细胞相比,具有 Oct4(+)-丰富细胞表型的细胞具有更高的增殖能力和 Oct4 mRNA 水平。Oct4 在 ESCC 中的过度表达表明它是 ESCC 治疗的潜在靶点。Oct4 可能是用于区分 ESCC 和食管黏膜的免疫组织化学面板中的有用肿瘤标志物。肿瘤球中 Oct4 的表达可能表明存在 ECSC 群体,其在异种移植肿瘤中的表达表明 Oct4 也与肿瘤转移有关。